-
1
-
-
85102220710
-
-
Chinese Source
-
Chinese Source
-
-
-
-
2
-
-
85102217880
-
-
Chinese Source
-
Chinese Source
-
-
-
-
3
-
-
44949101395
-
Cytokines: From gut inflammation to colorectal cancer
-
Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008; 9: 375-380
-
(2008)
Curr Drug Targets
, vol.9
, pp. 375-380
-
-
Fantini, M.C.1
Pallone, F.2
-
4
-
-
85102218419
-
-
Chinese Source
-
Chinese Source
-
-
-
-
5
-
-
20144371215
-
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: A single-blind randomized controlled trial
-
Gionchetti P, D'Arienzo A, Rizzello F, Manguso F, Maieron R, Lecis PE, Valpiani D, Iaquinto G, An-nese V, Balzano A, Varoli G, Campieri M. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. J Clin Gastroenterol 2005; 39: 291-297
-
(2005)
J Clin Gastroenterol
, vol.39
, pp. 291-297
-
-
Gionchetti, P.1
D'arienzo, A.2
Rizzello, F.3
Manguso, F.4
Maieron, R.5
Lecis, P.E.6
Valpiani, D.7
Iaquinto, G.8
An-Nese, V.9
Balzano, A.10
Varoli, G.11
Campieri, M.12
-
6
-
-
61949101620
-
Long-term follow-up of ulcerative colitis in the Chinese population
-
Chow DK, Leong RW, Tsoi KK, Ng SS, Leung WK, Wu JC, Wong VW, Chan FK, Sung JJ. Long-term follow-up of ulcerative colitis in the Chinese population. Am J Gastroenterol 2009; 104: 647-654
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 647-654
-
-
Chow, D.K.1
Leong, R.W.2
Tsoi, K.K.3
Ng, S.S.4
Leung, W.K.5
Wu, J.C.6
Wong, V.W.7
Chan, F.K.8
Sung, J.J.9
-
7
-
-
40949151599
-
Immune system alterations in patients with inflammatory bowel disease during remission
-
Sventoraityte J, Zvirbliene A, Kiudelis G, Zalinkevi-cius R, Zvirbliene A, Praskevicius A, Kupcinskas L, Tamosiunas V. Immune system alterations in patients with inflammatory bowel disease during remission. Medicina(Kaunas) 2008; 44: 27-33
-
(2008)
Medicina(Kaunas)
, vol.44
, pp. 27-33
-
-
Sventoraityte, J.1
Zvirbliene, A.2
Kiudelis, G.3
Zalinkevi-Cius, R.4
Zvirbliene, A.5
Praskevicius, A.6
Kupcinskas, L.7
Tamosiunas, V.8
-
8
-
-
85102219366
-
-
Chinese Source
-
Chinese Source
-
-
-
-
9
-
-
0037853260
-
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in he-patocytes
-
Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Konia-ris LG, Furlanetto RW, Mooney RA. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in he-patocytes. J Biol Chem 2003; 278: 13740-13746
-
(2003)
J Biol Chem
, vol.278
, pp. 13740-13746
-
-
Senn, J.J.1
Klover, P.J.2
Nowak, I.A.3
Zimmers, T.A.4
Konia-Ris, L.G.5
Furlanetto, R.W.6
Mooney, R.A.7
-
10
-
-
49249132865
-
Putting out the fre: Coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins
-
Dimitriou ID, Clemenza L, Scotter AJ, Chen G, Guerra FM, Rottapel R. Putting out the fre: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev 2008; 224: 265-283
-
(2008)
Immunol Rev
, vol.224
, pp. 265-283
-
-
Dimitriou, I.D.1
Clemenza, L.2
Scotter, A.J.3
Chen, G.4
Guerra, F.M.5
Rottapel, R.6
-
11
-
-
33746190828
-
Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo
-
Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006; 177: 1679-1688
-
(2006)
J Immunol
, vol.177
, pp. 1679-1688
-
-
Li, Y.1
Chu, N.2
Rostami, A.3
Zhang, G.X.4
-
12
-
-
85102218066
-
-
Chinese Source
-
Chinese Source
-
-
-
-
13
-
-
33751555600
-
General nature of the STAT3-activated anti-inflammatory response
-
El Kasmi KC, Holst J, Coffre M, Mielke L, de Pauw A, Lhocine N, Smith AM, Rutschman R, Kaushal D, Shen Y, Suda T, Donnelly RP, Myers MG, Alexander W, Vignali DA, Watowich SS, Ernst M, Hilton DJ, Murray PJ. General nature of the STAT3-activated anti-inflammatory response. J Immunol 2006; 177: 7880-7888
-
(2006)
J Immunol
, vol.177
, pp. 7880-7888
-
-
El Kasmi, K.C.1
Holst, J.2
Coffre, M.3
Mielke, L.4
de Pauw, A.5
Lhocine, N.6
Smith, A.M.7
Rutschman, R.8
Kaushal, D.9
Shen, Y.10
Suda, T.11
Donnelly, R.P.12
Myers, M.G.13
Alexander, W.14
Vignali, D.A.15
Watowich, S.S.16
Ernst, M.17
Hilton, D.J.18
Murray, P.J.19
-
14
-
-
85102216081
-
-
Chinese Source
-
Chinese Source
-
-
-
-
15
-
-
0037097509
-
Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation
-
Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yo-shimura A, Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 2002; 168: 6404-6411
-
(2002)
J Immunol
, vol.168
, pp. 6404-6411
-
-
Berlato, C.1
Cassatella, M.A.2
Kinjyo, I.3
Gatto, L.4
Yo-Shimura, A.5
Bazzoni, F.6
|